{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T12:36:36Z","timestamp":1794054996787,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI110016"],"award-info":[{"award-number":["R21 AI110016"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R21 CA127099"],"award-info":[{"award-number":["R21 CA127099"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chemotherapy remains the standard of care for most cancers worldwide, however development of chemoresistance due to the presence of the drug-effluxing ATP binding cassette (ABC) transporters remains a significant problem. The development of safe and effective means to overcome chemoresistance is critical for achieving durable remissions in many cancer patients. We have investigated the energetic demands of ABC transporters in the context of the metabolic adaptations of chemoresistant cancer cells. Here we show that ABC transporters use mitochondrial-derived ATP as a source of energy to efflux drugs out of cancer cells. We further demonstrate that the loss of methylation-controlled J protein (MCJ) (also named DnaJC15), an endogenous negative regulator of mitochondrial respiration, in chemoresistant cancer cells boosts their ability to produce ATP from mitochondria and fuel ABC transporters. We have developed MCJ mimetics that can attenuate mitochondrial respiration and safely overcome chemoresistance in vitro and in vivo. Administration of MCJ mimetics in combination with standard chemotherapeutic drugs could therefore become an alternative strategy for treatment of multiple cancers.<\/jats:p>","DOI":"10.1038\/s41467-021-23071-6","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:03:17Z","timestamp":1620972197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":197,"title":["Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance"],"prefix":"10.1038","volume":"12","author":[{"given":"Emily L.","family":"Giddings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin P.","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Laffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina M.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Valenca-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Culp-Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Fortner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"East","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-5384","authenticated-orcid":false,"given":"Phoebe","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-1110","authenticated-orcid":false,"given":"Hugo","family":"Arias-Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8769-0926","authenticated-orcid":false,"given":"Karatatiwant S.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Silverstrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonseok","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-5359","authenticated-orcid":false,"given":"Shana","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Y.","family":"Bunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0624-974X","authenticated-orcid":false,"given":"Steven N.","family":"Fiering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-6104","authenticated-orcid":false,"given":"Dwight E.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Robey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domink","family":"Stich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-6490","authenticated-orcid":false,"given":"Angelo","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-2225","authenticated-orcid":false,"given":"Mercedes","family":"Rincon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"23071_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","volume":"56","author":"MM Gottesman","year":"2016","unstructured":"Gottesman, M. M., Lavi, O., Hall, M. D. & Gillet, J. P. Toward a better understanding of the complexity of cancer drug resistance. Annu. Rev. Pharm. Toxicol. 56, 85\u2013102 (2016).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"23071_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","volume":"18","author":"RJ Kathawala","year":"2015","unstructured":"Kathawala, R. J., Gupta, P., Ashby, C. R. Jr & Chen, Z. S. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist. Updat. 18, 1\u201317 (2015).","journal-title":"Drug Resist. Updat."},{"key":"23071_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C. & Gottesman, M. M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Disco. 5, 219\u2013234 (2006).","journal-title":"Nat. Rev. Drug Disco."},{"key":"23071_CR4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1101\/gr.184901","volume":"11","author":"M Dean","year":"2001","unstructured":"Dean, M., Rzhetsky, A. & Allikmets, R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11, 1156\u20131166 (2001).","journal-title":"Genome Res."},{"key":"23071_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey, R. W. et al. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat. Rev. Cancer 18, 452\u2013464 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"23071_CR6","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1073\/pnas.83.12.4538","volume":"83","author":"IB Roninson","year":"1986","unstructured":"Roninson, I. B. et al. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl Acad. Sci. USA 83, 4538\u20134542 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23071_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0021-9258(19)75806-2","volume":"262","author":"K Ueda","year":"1987","unstructured":"Ueda, K. et al. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J. Biol. Chem. 262, 505\u2013508 (1987).","journal-title":"J. Biol. Chem."},{"key":"23071_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1360704","volume":"258","author":"SP Cole","year":"1992","unstructured":"Cole, S. P. et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650\u20131654 (1992).","journal-title":"Science"},{"key":"23071_CR9","doi-asserted-by":"publisher","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","volume":"95","author":"LA Doyle","year":"1998","unstructured":"Doyle, L. A. et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl Acad. Sci. USA 95, 15665\u201315670 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23071_CR10","first-page":"5337","volume":"58","author":"R Allikmets","year":"1998","unstructured":"Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V. & Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58, 5337\u20135339 (1998).","journal-title":"Cancer Res."},{"key":"23071_CR11","first-page":"8","volume":"59","author":"K Miyake","year":"1999","unstructured":"Miyake, K. et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59, 8\u201313 (1999).","journal-title":"Cancer Res."},{"key":"23071_CR12","doi-asserted-by":"publisher","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","volume":"22","author":"SV Ambudkar","year":"2003","unstructured":"Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E. & Gottesman, M. M. P-glycoprotein: from genomics to mechanism. Oncogene 22, 7468\u20137485 (2003).","journal-title":"Oncogene"},{"key":"23071_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0076-6879(05)00025-X","volume":"400","author":"B Poolman","year":"2005","unstructured":"Poolman, B. et al. Functional analysis of detergent-solubilized and membrane-reconstituted ATP-binding cassette transporters. Methods Enzymol. 400, 429\u2013459 (2005).","journal-title":"Methods Enzymol."},{"key":"23071_CR14","doi-asserted-by":"publisher","first-page":"29546","DOI":"10.1074\/jbc.M304796200","volume":"278","author":"JS Patzlaff","year":"2003","unstructured":"Patzlaff, J. S., van der Heide, T. & Poolman, B. The ATP\/substrate stoichiometry of the ATP-binding cassette (ABC) transporter OpuA. J. Biol. Chem. 278, 29546\u201329551 (2003).","journal-title":"J. Biol. Chem."},{"key":"23071_CR15","doi-asserted-by":"publisher","first-page":"1242454","DOI":"10.1126\/science.1242454","volume":"342","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L., Poffenberger, M. C., Chang, C. H. & Jones, R. G. Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013).","journal-title":"Science"},{"key":"23071_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V. & Locasale, J. W. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem. Sci. 41, 211\u2013218 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"23071_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"23071_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On respiratory impairment in cancer cells. Science 124, 269\u2013270 (1956).","journal-title":"Science"},{"key":"23071_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace, D. C. Mitochondria and cancer. Nat. Rev. Cancer 12, 685\u2013698 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"23071_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong, W. X., Rabinowitz, J. D. & White, E. Mitochondria and Cancer. Mol. Cell 61, 667\u2013676 (2016).","journal-title":"Mol. Cell"},{"key":"23071_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/exd.12613","volume":"24","author":"M Cierlitza","year":"2015","unstructured":"Cierlitza, M. et al. Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations. Exp. Dermatol. 24, 155\u2013157 (2015).","journal-title":"Exp. Dermatol"},{"key":"23071_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch, A. et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell 23, 811\u2013825 (2013).","journal-title":"Cancer Cell"},{"key":"23071_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/2001-1326-2-3","volume":"2","author":"LN Abdullah","year":"2013","unstructured":"Abdullah, L. N. & Chow, E. K. Mechanisms of chemoresistance in cancer stem cells. Clin. Transl. Med. 2, 3 (2013).","journal-title":"Clin. Transl. Med"},{"key":"23071_CR24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med"},{"key":"23071_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.immuni.2016.02.018","volume":"44","author":"DP Champagne","year":"2016","unstructured":"Champagne, D. P. et al. Fine-tuning of CD8(+) T cell mitochondrial metabolism by the respiratory chain repressor MCJ dictates protection to influenza virus. Immunity 44, 1299\u20131311 (2016).","journal-title":"Immunity"},{"key":"23071_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01970-x","volume":"8","author":"L Barbier-Torres","year":"2017","unstructured":"Barbier-Torres, L. et al. The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury. Nat. Commun. 8, 2068 (2017).","journal-title":"Nat. Commun."},{"key":"23071_CR27","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1128\/MCB.00189-13","volume":"33","author":"K Hatle","year":"2013","unstructured":"Hatle, K. et al. MCJ\/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations. Mol. Cell Biol. 33, 2302\u20132314 (2013).","journal-title":"Mol. Cell Biol."},{"key":"23071_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16991-2","volume":"11","author":"L Barbier-Torres","year":"2020","unstructured":"Barbier-Torres, L. et al. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nat. Commun. 11, 3360 (2020).","journal-title":"Nat. Commun."},{"key":"23071_CR29","doi-asserted-by":"publisher","unstructured":"Fernandez-Cabezudo, M. J. et al. Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer. JCI insight 1, https:\/\/doi.org\/10.1172\/jci.insight.86873 (2016).","DOI":"10.1172\/jci.insight.86873"},{"key":"23071_CR30","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ygyno.2005.03.023","volume":"97","author":"G Strathdee","year":"2005","unstructured":"Strathdee, G. et al. Demethylation of the MCJ gene in stage III\/IV epithelial ovarian cancer and response to chemotherapy. Gynecol. Oncol. 97, 898\u2013903 (2005).","journal-title":"Gynecol. Oncol."},{"key":"23071_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-9236-2_2","volume":"1978","author":"T Nemkov","year":"2019","unstructured":"Nemkov, T., Reisz, J. A., Gehrke, S., Hansen, K. C. & D\u2019Alessandro, A. High-throughput metabolomics: isocratic and gradient mass spectrometry-based methods. Methods Mol. Biol. 1978, 13\u201326 (2019).","journal-title":"Methods Mol. Biol."},{"key":"23071_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy, M. P. How mitochondria produce reactive oxygen species. Biochem J. 417, 1\u201313 (2009).","journal-title":"Biochem J."},{"key":"23071_CR33","first-page":"5141","volume":"47","author":"CR Fairchild","year":"1987","unstructured":"Fairchild, C. R. et al. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47, 5141\u20135148 (1987).","journal-title":"Cancer Res"},{"key":"23071_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00424-006-0126-x","volume":"453","author":"KJ Linton","year":"2007","unstructured":"Linton, K. J. & Higgins, C. F. Structure and function of ABC transporters: the ATP switch provides flexible control. Pflug. Arch. 453, 555\u2013567 (2007).","journal-title":"Pflug. Arch."},{"key":"23071_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2015.03.001","volume":"35","author":"B Westermann","year":"2015","unstructured":"Westermann, B. The mitochondria-plasma membrane contact site. Curr. Opin. Cell Biol. 35, 1\u20136 (2015).","journal-title":"Curr. Opin. Cell Biol."},{"key":"23071_CR36","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1091\/mbc.e16-05-0286","volume":"27","author":"B Cunniff","year":"2016","unstructured":"Cunniff, B., McKenzie, A. J., Heintz, N. H. & Howe, A. K. AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion. Mol. Biol. Cell 27, 2662\u20132674 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"23071_CR37","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1039\/c2cc17629g","volume":"48","author":"AS Rao","year":"2012","unstructured":"Rao, A. S. et al. A turn-on two-photon fluorescent probe for ATP and ADP. Chem. Commun. (Camb.) 48, 3206\u20133208 (2012).","journal-title":"Chem. Commun. (Camb.)"},{"key":"23071_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08441-5","volume":"10","author":"MA Lobas","year":"2019","unstructured":"Lobas, M. A. et al. A genetically encoded single-wavelength sensor for imaging cytosolic and cell surface ATP. Nat. Commun. 10, 711 (2019).","journal-title":"Nat. Commun."},{"key":"23071_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neo.2018.06.008","volume":"20","author":"F Alessandrini","year":"2018","unstructured":"Alessandrini, F., Pezze, L., Menendez, D., Resnick, M. A. & Ciribilli, Y. ETV7-Mediated DNAJC15 repression leads to doxorubicin resistance in breast cancer cells. Neoplasia 20, 857\u2013870 (2018).","journal-title":"Neoplasia"},{"key":"23071_CR40","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1128\/MCB.01804-06","volume":"27","author":"KM Hatle","year":"2007","unstructured":"Hatle, K. M. et al. Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression. Mol. Cell Biol. 27, 2952\u20132966 (2007).","journal-title":"Mol. Cell Biol."},{"key":"23071_CR41","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/4042","volume":"4","author":"H Nagahara","year":"1998","unstructured":"Nagahara, H. et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4, 1449\u20131452 (1998).","journal-title":"Nat. Med"},{"key":"23071_CR42","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","volume":"285","author":"SR Schwarze","year":"1999","unstructured":"Schwarze, S. R., Ho, A., Vocero-Akbani, A. & Dowdy, S. F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569\u20131572 (1999).","journal-title":"Science"},{"key":"23071_CR43","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1083\/jcb.139.3.589","volume":"139","author":"S Addya","year":"1997","unstructured":"Addya, S. et al. Targeting of NH2-terminal-processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondrial P450MT2. J. Cell Biol. 139, 589\u2013599 (1997).","journal-title":"J. Cell Biol."},{"key":"23071_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.chembiol.2008.03.015","volume":"15","author":"KL Horton","year":"2008","unstructured":"Horton, K. L., Stewart, K. M., Fonseca, S. B., Guo, Q. & Kelley, S. O. Mitochondria-penetrating peptides. Chem. Biol. 15, 375\u2013382 (2008).","journal-title":"Chem. Biol."},{"key":"23071_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205\u2013214 (2015).","journal-title":"Cell"},{"key":"23071_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","volume":"370","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 370, 153\u2013164 (2016).","journal-title":"Cancer Lett."},{"key":"23071_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1042\/bse0500209","volume":"50","author":"A Tamaki","year":"2011","unstructured":"Tamaki, A., Ierano, C., Szakacs, G., Robey, R. W. & Bates, S. E. The controversial role of ABC transporters in clinical oncology. Essays Biochem. 50, 209\u2013232 (2011).","journal-title":"Essays Biochem."},{"key":"23071_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.drup.2012.02.002","volume":"15","author":"L Amiri-Kordestani","year":"2012","unstructured":"Amiri-Kordestani, L., Basseville, A., Kurdziel, K., Fojo, A. T. & Bates, S. E. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resist. Updat. 15, 50\u201361 (2012).","journal-title":"Drug Resist. Updat."},{"key":"23071_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol, W. H., Bounds, P. L. & Dang, C. V. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325\u2013337 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"23071_CR50","first-page":"4258","volume":"61","author":"V Shridhar","year":"2001","unstructured":"Shridhar, V. et al. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res. 61, 4258\u20134265 (2001).","journal-title":"Cancer Res."},{"key":"23071_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","volume":"27","author":"W Li","year":"2016","unstructured":"Li, W. et al. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. Drug Resist. Updat. 27, 14\u201329 (2016).","journal-title":"Drug Resist. Updat"},{"key":"23071_CR52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-1-60761-416-6_15","volume":"596","author":"HM Coley","year":"2010","unstructured":"Coley, H. M. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors. Methods Mol. Biol. 596, 341\u2013358 (2010).","journal-title":"Methods Mol. Biol."},{"key":"23071_CR53","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/bit.10488","volume":"81","author":"S Kohler","year":"2003","unstructured":"Kohler, S. & Stein, W. D. Optimizing chemotherapy by measuring reversal of P-glycoprotein activity in plasma membrane vesicles. Biotechnol. Bioeng. 81, 507\u2013517 (2003).","journal-title":"Biotechnol. Bioeng."},{"key":"23071_CR54","doi-asserted-by":"publisher","first-page":"15544","DOI":"10.1016\/S0021-9258(18)66748-1","volume":"261","author":"G Batist","year":"1986","unstructured":"Batist, G. et al. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem. 261, 15544\u201315549 (1986).","journal-title":"J. Biol. Chem."},{"key":"23071_CR55","first-page":"4943","volume":"43","author":"WG Harker","year":"1983","unstructured":"Harker, W. G., MacKintosh, F. R. & Sikic, B. I. Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs. Cancer Res. 43, 4943\u20134950 (1983).","journal-title":"Cancer Res."},{"key":"23071_CR56","doi-asserted-by":"publisher","first-page":"36501","DOI":"10.1074\/jbc.M602998200","volume":"281","author":"LM Huff","year":"2006","unstructured":"Huff, L. M., Lee, J. S., Robey, R. W. & Fojo, T. Characterization of gene rearrangements leading to activation of MDR-1. J. Biol. Chem. 281, 36501\u201336509 (2006).","journal-title":"J. Biol. Chem."},{"key":"23071_CR57","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/sj.bjc.6601370","volume":"89","author":"RW Robey","year":"2003","unstructured":"Robey, R. W. et al. Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br. J. Cancer 89, 1971\u20131978 (2003).","journal-title":"Br. J. Cancer"},{"key":"23071_CR58","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.bcp.2007.12.001","volume":"75","author":"RW Robey","year":"2008","unstructured":"Robey, R. W. et al. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem. Pharm. 75, 1302\u20131312 (2008).","journal-title":"Biochem. Pharm."},{"key":"23071_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s002800050654","volume":"40","author":"Z Zhan","year":"1997","unstructured":"Zhan, Z. et al. Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administration. Cancer Chemother. Pharm. 40, 245\u2013250 (1997).","journal-title":"Cancer Chemother. Pharm."},{"key":"23071_CR60","doi-asserted-by":"publisher","first-page":"25.2.1","DOI":"10.1002\/0471140856.tx2502s60","volume":"60","author":"AS Divakaruni","year":"2014","unstructured":"Divakaruni, A. S., Rogers, G. W. & Murphy, A. N. Measuring mitochondrial function in permeabilized cells using the seahorse XF analyzer or a clark-type oxygen electrode. Curr. Protoc. Toxicol. 60, 25.2.1\u201325.2.16 (2014).","journal-title":"Curr. Protoc. Toxicol."},{"key":"23071_CR61","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/trf.12975","volume":"55","author":"A D\u2019Alessandro","year":"2015","unstructured":"D\u2019Alessandro, A. et al. Routine storage of red blood cell (RBC) units in additive solution-3: a comprehensive investigation of the RBC metabolome. Transfusion 55, 1155\u20131168 (2015).","journal-title":"Transfusion"},{"key":"23071_CR62","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/rcm.7834","volume":"31","author":"T Nemkov","year":"2017","unstructured":"Nemkov, T., Hansen, K. C. & D\u2019Alessandro, A. A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways. Rapid Commun. Mass Spectrom. 31, 663\u2013673 (2017).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"23071_CR63","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/trf.13892","volume":"57","author":"A D\u2019Alessandro","year":"2017","unstructured":"D\u2019Alessandro, A. et al. Citrate metabolism in red blood cells stored in additive solution-3. Transfusion 57, 325\u2013336 (2017).","journal-title":"Transfusion"},{"key":"23071_CR64","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, 724\u2013740.e724 (2018).","journal-title":"Cancer Cell"},{"key":"23071_CR65","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"23071_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinforma. 18, 529 (2017).","journal-title":"BMC Bioinforma."},{"key":"23071_CR67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23071-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23071-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23071-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T11:01:46Z","timestamp":1675335706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23071-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23071"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23071-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"assertion":[{"value":"1 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M. Rincon and T. Thornton have a patent application related to this work. K.F. was supported by Mitotherapeutics LLC. M. Rincon is a co-founder and a member of the Scientific Advisory Board of Mitotherapeutix LLC. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2804"}}